Objectives
1. Describe relationships between markers of CKD severity and outcomes.
2. Weigh accumulating evidence for novel biomarkers for CKD and CVD in patients with CKD and kidney transplant recipients.
Session date:
09/27/2018 - 1:00pm to 2:00pm CDT
Location:
UCMC
AMB S-534
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Brad Astor, PhD, MPH